NASDAQ:RCEL

Avita Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy RCEL

*Your capital is at risk

$4.16

-0.0300 (-0.716%)

At Close: Jun 03, 2026

AVITA Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.45M and sold 0 RCEL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	3.45M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 21, 2025 Buy	Common Stock A-Award	Cook Jeremy Curnock Director	Director	10 022 Value: $87.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	Mcnamara Robert Director	Director	4 295 Value: $37.5K
Jan 21, 2025 Buy	Common Stock A-Award	Mcnamara Robert Director	Director	10 022 Value: $87.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	Reed Jan Stern Director	Director	4 295 Value: $37.5K
Jan 21, 2025 Buy	Common Stock A-Award	Reed Jan Stern Director	Director	10 022 Value: $87.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	Vance Cary Guy Director	Director	4 295 Value: $37.5K
Jan 21, 2025 Buy	Common Stock A-Award	Vance Cary Guy Director	Director	10 022 Value: $87.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	O'toole David D CFO	C-Suite Officer	150 000 Value: $1.31M
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	Kelsey Nicole Chief Legal Officer	Officer	65 000 Value: $567.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	Kelsey Nicole Chief Legal Officer	Officer	65 000 Value: $567.5K
Jan 21, 2025 Buy	Stock Options (Right to Buy) A-Award	O'toole David D CFO	C-Suite Officer	150 000 Value: $1.31M
Dec 09, 2024 Buy	Common Stock P-Purchase	Crowe Suzanne Director	Director	486 Value: $6K
Dec 09, 2024 Buy	Common Stock P-Purchase	Crowe Suzanne Director	Director	486 Value: $6K
Dec 05, 2024 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	500 Value: $6K
Dec 05, 2024 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	475 Value: $6K
Dec 05, 2024 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	475 Value: $6K
Dec 05, 2024 Buy	Common Stock P-Purchase	O'toole David D CFO	C-Suite Officer	500 Value: $6K
Nov 29, 2024 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	785 Value: $6K
Nov 29, 2024 Buy	Common Stock A-Award	O'toole David D CFO	C-Suite Officer	785 Value: $6K
Aug 19, 2024 Buy	Common Stock A-Award	Mcnamara Robert Director	Director	10 000 Value: $90.0K
Aug 19, 2024 Buy	Common Stock A-Award	Mcnamara Robert Director	Director	10 000 Value: $90.0K
Jul 01, 2024 Buy	Stock Options (Right to Buy)	Kelsey Nicole Chief Legal/compliance Officer	Officer	150 000 Value: $1.16M
Jul 01, 2024 Buy	Stock Options (Right to Buy)	Kelsey Nicole Chief Legal/compliance Officer	Officer	150 000 Value: $1.16M
Jun 05, 2024 Buy	Common Stock A-Award	Panaccio Lou Director	Director	9 200 Value: $87.5K
Jun 05, 2024 Buy	Stock Options (Right to Buy) A-Award	Panaccio Lou Director	Director	3 943 Value: $37.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AVITA MEDICAL, INC.

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a ...

Read Full Profile Here